IACR Satellite Meeting 2024

The IACR is holding a 1-day Satellite meeting in RCSI – 26th February 2024. Registration for IACR members is 25 Euro and places are limited to only 150 participants.  

IACR 2024 Membership + Registration

1-day Satellite Meeting Agenda

Key Note Speakers

IACR Guest Lecturer

Prof. Jacintha O'Sullivan

Prof. Jacintha O'Sullivan

Professor in Translational Oncology and Education Lead for the Trinity St. James’s Cancer Institute.

Prof. O Sullivan directs a translational gastrointestinal (GI) research team in the Trinity Translational Medicine Institute (TTMI) in collaboration with clinical and surgical colleagues and patient involvement. She is also the Education lead for the Trinity St. James’s Cancer Institute. She utilises well established bio-banking structures to drive this GI translational research program.

Prof. O Sullivan’s current translational research themes include:


1. Development of diagnostic platforms to stratify cancer risk and response to targeted therapies for gastrointestinal diseases.

2. Development of novel patented therapeutics to be used in the neoadjuvant and adjuvant treatment setting for gastrointestinal cancer patients (Colorectal and Oesophageal cancers).


3. Elucidating how the tumour microenvironment cross talks to the immune system in Gastrointestinal diseased patients.


4. Importance of metabolism, inflammation, and obesity in driving disease progression and in regulating treatment response in GI diseases.

5. Advancing new experimental technologies to boost treatment response in the resistant tumour microenvironment.
The outputs of these translational themes will benefit patient care, treatment, and management for gastrointestinal diseased patients.

Irish Cancer Society Guest Lecturer

Dr Emer Guinan

Dr Emer Guinan

Associate Professor in Cancer Rehabilitation and Survivorship, School of Medicine, Trinity College Dublin

Dr Emer Guinan is an Associate Professor in Cancer Rehabilitation and Survivorship, in the School of Medicine in Trinity College, with responsibility for building capacity in cancer survivorship research and education across the Trinity St James”s Cancer Institute (TSJCI).

She holds multiple administrative positions at the TSCJ including co-course coordinator of the MSc in Cancer Survivorship, a member of the TJSCI Education Advisory Board co-chair of the TSJCI Cancer Survivorship Network. A CORU registered physiotherapists, her primary expertise is in intervention development and evaluation to manage unmet cancer survivorship needs.

Her work has delivered 70 peer reviewed publications and she has received >€3 million in external grant funding, including >€300,000 as Principal Investigator.

She has fulfilled multiple research roles over her career including trial project manager (PREPARE & ReStOre trials), protocol development group for an international multi-site randomised controlled trial (INTERVAL-GAP4 trial), trial management group committee (ExPeCT, ReStOre & PreHIIT trials), co-Principal Investigator (PreHIIT trial) and Principal Investigator (PERCS), and has supervised numerous postgraduate student projects.

Breakthrough Cancer Research Guest Lecturer

Prof Christopher Scott

Prof Christopher Scott

Dean of Research, Faculty of Medicine, Health and Life Sciences, QUB

Following a primary degree in Biochemistry he undertook a PhD and post doctoral training at Queen’s in molecular enzymology. In 2001, Chris was one of the founding members of QUB spinout company Fusion Antibodies Ltd., before returning to Queen’s in 2003 to take up an academic position.

Chris is internationally renowned for his work in development of antibody and nanomedicine-based therapies for the treatment of cancer and other conditions. Work in his laboratory is funded by agencies such as Medical Research Council, US-Ireland, and various industrial sources such as AstraZeneca and Immunocore.

He also held a Royal Society Industrial Fellowship with GSK from 2012-15, and won the Vice Chancellor’s Prize for Innovation in 2015 with his group’s work on developing a novel nanomedicine for the treatment of sepsis and other inflammatory conditions. Chris is co-founder of Aviceda Therapeutics and AilseVax Ltd.

PPI Session Speakers

Prof Amanda McCann

Prof Amanda McCann

UCD

Kay McKeon

Kay McKeon

IACR PPI Council Champion

Krista Costello

Krista Costello

IACR PPI Council Member

Aideen McCabe

Aideen McCabe

UCC

Dr Seodhna Lynch

Dr Seodhna Lynch

Ulster University

Adele Connor

Adele Connor

UCD

Deirdre O'Raw

Deirdre O'Raw

UCD PPI Group Partner

Bridget Carr

Bridget Carr

UCD PPI Group Partner

Dr Nikolette Warner

Dr Nikolette Warner

Cancer Survivorship Research Officer, Irish Cancer Society

Dr Arman Rahman

Dr Arman Rahman

Assistant Professor in the UCD School of Medicine, and Principal Investigator in the Cancer Biology and Therapeutics Laboratory

Dr Sarah McLoughlin

Dr Sarah McLoughlin

PPI Coordinator, Cancer Trials Ireland

Dr Claire Kilty

Dr Claire Kilty

Head of Research, Irish Cancer Society

Prof. Patrick G. Johnston Award for Excellence in Cancer Research Outreach

Mon, 26 February 2024, 18:15 – 19:15 

Six early career researchers have been selected based on their lay abstract submissions to IACR 2023. Those selected will take part in a patient communication workshop prior to IACR 2023 and will prepare a lay presentation on their work. Presentations will be delivered to peers and a lay audience at The Patrick G. Johnston Award for Excellence in Cancer Research. The winner is chosen by the audience and judging panel. Every year the event is open to the public.

 

Charlotte Andrieu

Charlotte Andrieu

DCU

Charlotte is a postdoctoral researcher in bioinformatics and cancer genomics. She works in Assoc. Prof. Naomi Walsh's lab in Dublin City University. Her research involves exploring the clinical potential of in vitro cancer models and their impact on personalised medicine.

Christina Cahill

Christina Cahill

Trinity St James's Cancer Institute

My name is Christina and I am a fourth year PhD student from Kildare. I graduated from Trinity College Dublin in 2018 with a BA in Molecular Medicine. Following my undergraduate degree, I worked as a research assistant before beginning my PhD in 2020 in Trinity St. James’s Cancer Institute. Here I work with Dr. Niamh Lynam-Lennon and Prof. Jacintha O’Sullivan in the Department of Surgery to investigate the role of microRNA in the treatment response of oesophageal and gastric cancer.

David Hackett

David Hackett

TCD

My name is David Hackett, and I'm a second year PhD student from Kildare. I graduated with a BSc in Pharmacology from University College Dublin in 2022. During my undergraduate studies, I undertook an Erasmus semester at the University of Copenhagen, where I worked within a translational cancer research group. This experience marked the true beginning of my passion for cancer research. I was awarded the Musgrave Breakthrough Cancer Research PhD scholarship in 2022 to undertake a PhD with Dr. Stephen Maher and Dr. Adriele Prina-Mello at Trinity College Dublin. My project focuses on exploring the potential of a new type of synthetic genetic drug to enhance the effectiveness of chemotherapy and radiotherapy in pancreatic cancer.

Faye Lewis

Faye Lewis

TCD

My name is Faye, and I am a second year PhD student from County Laois. I completed a B.A. (Mod) in Physiology and M.Sc. in Immunology in Trinity College Dublin. After completing my master’s degree, I started my PhD in the Trinity Centre for Health Sciences on the St. James’s Hospital campus. I work in the area of gynaecological oncology, focusing on the clinical utility of liquid biopsies in ovarian cancers.

Niamh McAuley

Niamh McAuley

RCSI

My name is Niamh and I am a second year PhD student at RCSI. I graduated from TUD in 2021 with a BSc in Pharmaceutical Healthcare. Following this I worked as a research assistant developing my skills in the laboratory with Dr. Sinead Toomey. In late 2022 I began my PhD in cancer research, supervised by Prof. Ann Hopkins and Prof. Siobhan Glavey. My project focuses on designing and testing new drugs for potential use in Multiple Myeloma (MM). MM is an incurable blood cancer which is unfamiliar to most people. Accordingly, one aspect of this project that I am most passionate about is spreading MM awareness in our community. To achieve this goal, our group and a patient panel co-created a lay-friendly MM booklet for distribution to hospitals and GP surgeries across the country.

Niamh Scully

Niamh Scully

RCSI

My name is Niamh, and I am a 2nd year PhD student in the Royal College of Surgeons. I graduated with an MSc in Molecular Medicine from Trinity College Dublin in 2021. I then worked as a chemical analyst in an industrial chemical engineering company called Schlotter for one year before beginning my PhD studies in September 2022. I work with Professor Brona Murphy in the department of Physiology & Medical Physics, where we focus on investigating the effects the hypoxic tumour microenvironment has on drug response and disease behaviour in a clinically relevant 3D model of a complex brain tumour called Glioblastoma.

Thank You to our Sponsors

 2024 Charity / Educational Sponsors

Irish Cancer Society<br />
Breakthrough Cancer Resesarch<br />
AICRI Start<br />
Cross Cancer Research<br />
EACR

 2024 Gold Sponsor

IACR2022-Gold-Sponsors

 2024 Silver Sponsors

Silver Sponsors - MSC and Thermo Fisher Scientific

Donate to Cancer Research

All donations to the IACR go directly towards supporting early-stage oncology scientific researchers in their work.

Contact Us

Contact Us
Irish Association for Cancer Research
9A Coolkill, Sandyford, Dublin 18

T: +353 (0)1 295 8859
E: info@iacr.ie

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.

Registered Charity Number (RCN): 20030117

Design by patterns.ie
© 2022